TGM2 and myeloid sarcoma: TG2 immunoreactivity was also found in activated microglia and hypertrophic astrocytes in active and chronic active MS lesions (van Strien et al., 2011c; Espitia Pinzón et al., 2017a), likely induced by inflammatory mediators that are present.